• Acne
  • Actinic Keratosis
  • Aesthetics
  • Alopecia
  • Atopic Dermatitis
  • Buy-and-Bill
  • COVID-19
  • Case-Based Roundtable
  • Chronic Hand Eczema
  • Drug Watch
  • Eczema
  • General Dermatology
  • Hidradenitis Suppurativa
  • Melasma
  • NP and PA
  • Pediatric Dermatology
  • Pigmentary Disorders
  • Practice Management
  • Precision Medicine and Biologics
  • Prurigo Nodularis
  • Psoriasis
  • Psoriatic Arthritis
  • Rare Disease
  • Rosacea
  • Skin Cancer
  • Vitiligo
  • Wound Care

Opinion

Video

Final Thoughts: The Importance of Comparative Studies in AD

Author(s):

Christopher G. Bunick, MD, PhD,Raj Chovatiya, MD, PhD, MSCI

Panelists offer concluding insights and emphasize the critical role of comparative studies in advancing atopic dermatitis treatment strategies.

Current Time 0:00
Duration 0:00
Loaded: 0%
Stream Type LIVE
Remaining Time 0:00
 
1x
    • Chapters
    • descriptions off, selected
    • captions off, selected

      Related Videos
      1 expert in this video
      Balancing Effective AD Symptom Control with Long-Term Safety in New Therapies
      1 expert in this video
      Key Considerations for Evaluating Ruxolitinib Cream as a Treatment for Young Children
      1 expert in this video
      Supporting Caregivers in Successful Long-Term Atopic Dermatitis Management: The Role of Dermatologists
      1 expert in this video
      Challenges and Emerging Solutions in Treatment for Age Groups: Addressing Disease Control, Safety, and Usability
      1 expert in this video
      Challenges and Unmet Needs in Treating Pediatric Atopic Dermatitis
      Utilizing Gene Expression Profiling to Avoid Unnecessary Interventions in a 72-Year-Old Woman With Melanoma
      Utilizing Gene Expression Profiling to Avoid Unnecessary Interventions in a 72-Year-Old Woman With Melanoma
      4 experts are featured in this series.
      Differentiating Between JAK Inhibitors in Clinical Practice
      2 experts in this video
      IL-17 Inhibitor Treatment Impact on Quality of Life in Psoriasis and Psoriatic Arthritis
      2 experts in this video
      Clinical Attributes of IL-17 Inhibitors in Psoriasis
      4 experts are featured in this series.
      Laboratory Monitoring with Oral JAK Inhibitors
      Related Content
      Experts Delve Into Upadacitinib vs Dupilumab: Insights From LEVEL UP
      October 9th 2024

      Experts Delve Into Upadacitinib vs Dupilumab: Insights From LEVEL UP

      The Cutaneous Connection: Episode 1- Cannabinoid Use in Dermatology
      June 25th 2020

      The Cutaneous Connection: Episode 1- Cannabinoid Use in Dermatology

      Reviewing New Tapinarof Data for Atopic Dermatitis Treatment
      December 20th 2023

      Reviewing New Tapinarof Data for Atopic Dermatitis Treatment

      Phase 2 Trial of ADX-629 Underway for Treatment of AD
      April 10th 2023

      Phase 2 Trial of ADX-629 Underway for Treatment of AD

      Christoph R. Loeser, MD, IFAAD
      March 14th 2023

      Dermatologist Shares Insights on Saving the Nail at Annual Meeting

      Considering and Improving Patient Quality of Life in Dermatologic Conditions
      March 10th 2023

      Considering and Improving Patient Quality of Life in Dermatologic Conditions

      © 2025 MJH Life Sciences

      All rights reserved.